Work

First-in-human study of BG-C9074, a B7-H4-targeting ADC in patients with advanced solid tumors: Preliminary results of the dose-escalation phase.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.3033

Authors: Cesar Augusto Perez, Linda R. Mileshkin, Saana D'Alonzo, Garret Albert Winkler, Shuai Yuan, Hugh Giovinazzo, Zhaoyin Zhu, Ramil Abdrashitov, Binghe Xu

Institutions: Peter MacCallum Cancer Centre, BeOne Medicines (Switzerland), Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814348

Cites:

Cited by: 6

Related to: 10